• Hematology / Oncology @Point of Care Podcasts

  • By: @Point of Care
  • Podcast

Hematology / Oncology @Point of Care Podcasts

By: @Point of Care
Listen for free

  • Summary

  • Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.
    Copyright 2020 At Point of Care, LLC. All rights reserved.
    Show more Show less
Hygiene & Healthy Living Physical Illness & Disease
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • S21:E2 – Individualizing Care Plans for Patients With AML

    S21:E2 – Individualizing Care Plans for Patients With AML
    Sep 30 2024

    In this episode, Individualizing Care Plans for Patients With AML, Dr. Amer Zeidan and Dr. Guillermo Garcia-Manero discuss how to incorporate evidence-based treatment plans for patients with AML who are receiving oral HMA maintenance therapy. Who are the best candidates for these therapies?

    Visit https://suiteweb.atpointofcare.com/#library/mds-aml/2646.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
    Show more Show less
    24 mins
  • S21:E1 – Improving Survival With HMA Maintenance Therapy in AML

    S21:E1 – Improving Survival With HMA Maintenance Therapy in AML
    Sep 30 2024

    In this episode, Improving Survival With HMA Therapy in AML, Dr. Amer Zeidan and Dr. Guillermo Garcia-Manero discuss the latest clinical trial evidence for using hypomethylating agents as maintenance therapy for AML patients as well as which patients will benefit most from these therapies.

    Visit https://suiteweb.atpointofcare.com/#library/mds-aml/2646.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
    Show more Show less
    42 mins
  • S21:E3 – Identifying and Managing Treatment-Related Adverse Events (TRAEs) Associated With TROP2-Targeting Therapies

    S21:E3 – Identifying and Managing Treatment-Related Adverse Events (TRAEs) Associated With TROP2-Targeting Therapies
    Jan 29 2024

    In this episode, our faculty discuss the widespread expression of human epidermal growth factor receptor 3 (HER3) across tumor types and why clinicians should have HER3 on their radar. Visit https://suitehome.atpointofcare.com/library/2606.13/page/0?subdomain=nsclc to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
    Show more Show less
    23 mins

What listeners say about Hematology / Oncology @Point of Care Podcasts

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available